½ÃÀ庸°í¼­
»óǰÄÚµå
1672755

È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤¹ý ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, »ùÇà À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°

Chemiluminescence Immunoassay Market, By Product Type, By Application, By Sample Type, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤¹ý ¼¼°è ½ÃÀåÀº 2025³â¿¡ 140¾ï ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 6.8%·Î ¼ºÀåÇÏ¿© 2032³â¿¡´Â 222¾ï 1õ¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 140¾ï ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£: 2025-2032³â CAGR 6.80% 2032³â °¡Ä¡ ¿¹Ãø 222¾ï 1,000¸¸ ´Þ·¯
±×¸². È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤¹ý ½ÃÀå Á¡À¯À²(%), 2025³â Áö¿ªº°
Chemiluminescence Immunoassay Market-IMG1

È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤¹ýÀº ¾×ü »ùÇÿ¡¼­ Ç׿ø, Ç×ü ¹× ±âŸ ´Ü¹éÁúÀÇ °ËÃâ ¹× Á¤·®¿¡ »ç¿ëµÇ´Â »ýÈ­ÇÐÀû °Ë»ç ±â¼úÀÔ´Ï´Ù. Ç׿ø Ç×ü ¹ÝÀÀÀÇ Æ¯À̼º°ú ¹ß±¤ ¹ÝÀÀÀ» Á¶ÇÕÇÏ¿© ¹ß±¤°è·Î ÃøÁ¤ °¡´ÉÇÑ ±¤ÀÚ ½ÅÈ£¸¦ »ý¼ºÇÕ´Ï´Ù. ÀÌ ±â¼úÀº ³ôÀº °¨µµ¿Í ½Å·Ú¼ºÀ¸·Î ÀÎÇØ ÀÓ»ó Áø´Ü¿¡¼­ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù. Àå±â°£ÀÇ ÀÎÅ¥º£À̼ÇÀ̳ª ¼¼Á¤ °úÁ¤À» ÇÊ¿ä·Î ÇÏÁö ¾Ê°í, Ç÷ûÀ̳ª Ç÷Àå ÁßÀÇ ÇÇÄÚ±×·¥ ¶Ç´Â ÆèÅä±×·¥ ³óµµÀÇ ´Ù¾çÇÑ ¹ÙÀÌ¿À¸¶Ä¿¸¦ Á÷Á¢ ÃøÁ¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤¹ý ¼¼°è ½ÃÀåÀÇ ¼ºÀåÀº ÀÓ»ó Áø´Ü¿¡¼­ ¼±ÁøÀû ¸é¿ªÃøÁ¤ ±â¼ú¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Áúº´ ½ºÅ©¸®´×, Ä¡·á ¸ð´ÏÅ͸µ, ³»ºÐºñÇÐ µî Æø³ÐÀº ¿ëµµ°¡ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µË´Ï´Ù.

½ÃÀå ¿ªÇÐ

È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤¹ý ¼¼°è ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ³ëÀÎ Áõ°¡¿Í ¸¸¼º Áúȯ°ú °¨¿°ÀÇ È®»êÀÔ´Ï´Ù. WHO¿¡ µû¸£¸é ¸¸¼º ÁúȯÀº Àü ¼¼°è ¿¬°£ »ç¸ÁÀÚ ¼öÀÇ 60% ÀÌ»óÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¶ÇÇÑ º´¿ø°ú Áø´Ü¼¾ÅͰ¡ ÀÇ·á½Ã¼³À» Áøº¸ÀûÀÎ Áø´Ü Ç÷§ÆûÀ¸·Î ¾÷±×·¹À̵åÇϱâ À§ÇÑ ÅõÀÚ¸¦ ´Ã¸®°í ÀÖ´Â °Íµµ ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÅÁ¦Ç° ½ÂÀÎÀ» À§ÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ Áöħ°ú Àü¹® Àåºñ ¹× ±â¼úÀÚÀÇ Çʿ伺ÀÌ ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå °³Ã´ÀÚ´Â º¸´Ù ³ôÀº 󸮷®°ú Çâ»óµÈ Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î ±â´ÉÀ» °®Ãá ¿ÏÀü ÀÚµ¿È­µÈ ÄÄÆÑÆ®ÇÑ È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤¹ý ½Ã½ºÅÛÀ» °³¹ßÇÒ ¼ö ÀÖ´Â ±âȸ°¡ ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

º» º¸°í¼­¿¡¼­´Â ¼¼°èÀÇ È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤¹ý ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ¿¬µµ·Î ÇÑ ¿¹Ãø±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬°£ Æò±Õ ¼ºÀå·ü(CAGR%)À» Á¦°øÇÕ´Ï´Ù.

´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÃÄ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í,ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾ÈÀÇ ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç°ÀÇ »ó½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ª¿¡ ÀÇÇÑ Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ °íÂûµµ Á¦°øÇÕ´Ï´Ù.

¼¼°èÀÇ È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤¹ý ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀº ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ¼º°ú, Àü·« µîÀÇ ¸Å°³º¯¼ö¸¦ ±â¹ÝÀ¸·Î °ÔÀçµË´Ï´Ù.

ÁÖ¿ä ±â¾÷Àº Roche Diagnostics, Abbott, Siemens Healthcare, Beckman Coulter, Ortho-Clinical Diagnostics, BioMerieux µîÀÌ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÅëÂûÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, ŸÀÌÇÎ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤¹ý ¼¼°è ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, ÆÇ¸ÅÀÚ, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº ¼¼°èÀÇ È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤¹ý ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤ÀÌ ¿ëÀÌÇØÁý´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map (COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • ¿µÇ⠺м®
  • ½ÃÀå µ¿Çâ
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Àμö¿Í Á¦ÈÞ ½Ã³ª¸®¿À
  • ÀÚ±Ý Á¶´Þ ¹× ÅõÀÚ
  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®

Á¦4Àå ¼¼°èÀÇ È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤¹ý ½ÃÀå - COVID-19 ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ÀüüÀûÀÎ ¿µÇâ
  • Á¤ºÎÀÇ ´ëó
  • COVID-19¿¡ ÀÇÇÑ ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤¹ý ½ÃÀå, Á¦Ç° À¯Çüº°, 2020-2032³â(10¾ï ´Þ·¯)

  • ¼Ò°³
  • ºÐ¼®±â
  • ÀÚµ¿È­
  • ¹ÝÀÚµ¿
  • ½Ã¾à
  • ¹ß±¤Ã¼ ¸¶Ä¿
  • È¿¼Ò ¸¶Ä¿
  • ¼Ò¸ðǰ

Á¦6Àå ¼¼°èÀÇ È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤¹ý ½ÃÀå, ¿ëµµº°, 2020-2032³â(10¾ï ´Þ·¯)

  • ¼Ò°³
  • Ä¡·á ¸ð´ÏÅ͸µ
  • Á¾¾çÇÐ
  • ³»ºÐºñÇÐ
  • °¨¿°Áõ
  • ÀÚ°¡¸é¿ªÁúȯ
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤¹ý ½ÃÀå, »ùÇà À¯Çüº°, 2020-2032³â(10¾ï ´Þ·¯)

  • ¼Ò°³
  • Ç÷¾×
  • ¼Òº¯
  • Ÿ¾×
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤¹ý ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°, 2020-2032³â(10¾ï ´Þ·¯)

  • ¼Ò°³
  • º´¿ø
  • ÀÓ»ó ½ÇÇè½Ç
  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • ±âŸ

Á¦9Àå ¼¼°èÀÇ È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤¹ý ½ÃÀå, Áö¿ªº°, 2020-2032³â(10¾ï ´Þ·¯)

  • ¼Ò°³
  • ºÏ¹Ì
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦10Àå °æÀï ±¸µµ

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Siemens AG
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd.
    • Danaher Corporation
    • bioMerieux SA
    • Johnson & Johnson
    • Tosoh Corporation
    • Randox Laboratories
    • DiaSorin SpA
    • PerkinElmer, Inc.
    • Mindray Bio-Medical Electronics Co., Ltd.
    • Getein BIoTech, Inc.
    • QuidelOrtho Corporation
    • Sysmex Corporation
    • Ortho Clinical Diagnostics
    • Abcam plc
    • Thermo Fisher Scientific Inc.
    • Hologic, Inc.

Á¦11Àå ºÐ¼®°¡ Ãßõ

  • À¶¼º°ú ¼èÅð
  • ÀϰüÇü ±âȸ ¸Ê

Á¦12Àå Âü°í¹®Çå°ú Á¶»ç¹æ¹ý

  • Âü°í¹®Çå
  • Á¶»ç ¹æ¹ý
SHW 25.03.26

Global Chemiluminescence Immunoassay Market is estimated to be valued at USD 14.00 Bn in 2025 and is expected to reach USD 22.21 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 14.00 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.80% 2032 Value Projection: USD 22.21 Bn
Figure. Chemiluminescence Immunoassay Market Share (%), By Region 2025
Chemiluminescence Immunoassay Market - IMG1

Chemiluminescence immunoassay is a biochemical test technique that is used for detecting and quantifying antigens, antibodies, and other proteins in a liquid sample. It combines the specificity of antigen-antibody reaction with a luminescent reaction to produce a photon signal that can be measured with a luminometer. The technique has gained popularity in clinical diagnostics, owing to its high sensitivity and reliability. It allows measurement of various biomarkers at picogram or femtogram concentrations directly in serum or plasma without requiring lengthy incubations or wash steps. Global chemiluminescence immunoassay market growth is driven by growing need for advanced immunoassay techniques in clinical diagnostics. Its wide applications in disease screening, therapeutic drug monitoring, and endocrinology can drive the market growth.

Market Dynamics:

Global chemiluminescence immunoassay market growth is driven by rising geriatric population and growing prevalence of chronic and infectious diseases. According to WHO, chronic diseases are estimated to account for over 60% of all deaths globally each year. Moreover, increasing investments by hospitals and diagnostic centers to upgrade their medical facilities with advanced diagnostic platforms can drive the market growth. However, stringent regulatory guidelines for new product approvals and the need for specialized equipment and technicians can hamper the market growth. The market players have opportunities to develop fully automated, compact chemiluminescence immunoassay systems with higher throughput and enhanced point-of-care capabilities..

Key Features of the Study:

This report provides in-depth analysis of the global chemiluminescence immunoassay market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global chemiluminescence immunoassay market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Roche Diagnostics, Abbott, Siemens Healthcare, Beckman Coulter, Ortho-Clinical Diagnostics, and BioMerieux

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global chemiluminescence immunoassay market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chemiluminescence immunoassay market

Detailed Segmentation-

  • By Product Type
    • Analyzers
    • Automated
    • Semi-automated
    • Reagents
    • Luminophore Markers
    • Enzymatic Markers
    • Consumables
  • By Application
    • Therapeutic Drug Monitoring
    • Oncology
    • Cardiology
    • Endocrinology
    • Infectious Disease
    • Autoimmune Disease
    • Others
  • By Sample Type
    • Blood
    • Urine
    • Saliva
    • Other Sample Types
  • By End User
    • Hospitals
    • Clinical Laboratories
    • Pharmaceutical and Biotechnology Companies
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Siemens AG
    • Abbott Laboratories
    • Hoffmann-La Roche Ltd.
    • Danaher Corporation
    • bioMerieux SA
    • Johnson & Johnson
    • Tosoh Corporation
    • Randox Laboratories
    • DiaSorin S.p.A.
    • PerkinElmer, Inc.
    • Mindray Bio-Medical Electronics Co., Ltd.
    • Getein Biotech, Inc.
    • QuidelOrtho Corporation
    • Sysmex Corporation
    • Ortho Clinical Diagnostics
    • Abcam plc
    • Thermo Fisher Scientific Inc.
    • Hologic, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Application
    • Market Snapshot, By Sample Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Chemiluminescence Immunoassay Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Chemiluminescence Immunoassay Market, By Product Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Analyzers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Automated
  • Semi-automated
  • Reagents
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Luminophore Markers
  • Enzymatic Markers
  • Consumables

6. Global Chemiluminescence Immunoassay Market, By Application, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Therapeutic Drug Monitoring
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Oncology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Endocrinology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Infectious Disease
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Autoimmune Disease
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Chemiluminescence Immunoassay Market, By Sample Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Blood
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Urine
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Saliva
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other Sample Types
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Chemiluminescence Immunoassay Market, By End User, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Clinical Laboratories
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pharmaceutical and Biotechnology Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Chemiluminescence Immunoassay Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Company Profiles
    • Siemens AG
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd.
    • Danaher Corporation
    • bioMerieux SA
    • Johnson & Johnson
    • Tosoh Corporation
    • Randox Laboratories
    • DiaSorin S.p.A.
    • PerkinElmer, Inc.
    • Mindray Bio-Medical Electronics Co., Ltd.
    • Getein Biotech, Inc.
    • QuidelOrtho Corporation
    • Sysmex Corporation
    • Ortho Clinical Diagnostics
    • Abcam plc
    • Thermo Fisher Scientific Inc.
    • Hologic, Inc.

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦